Abstract:Abstract Pediatric glioblastoma multiforme (pGBM) is a highly aggressive brain tumor with poor prognosis. Resistance to ionizing radiation, which is one of the major therapeutic regimes, is believed to play a critical role in tumor recurrence and ultimate treatment failure. However, little is known about the cellular and molecular mechanisms of radioresistance in pGBM, particularly the in vivo responses of tumor cells toward clinically relevant fractionated radiotherapy. To gain a better understanding of the radioresistance mechanisms, we administered fractionated radiation (2Gy per day × 5 times) to SCID mice bearing pre-established orthotopic xenograft tumors derived from two independent fresh patient tumors. Examination of the xenograft tumors immediately at the end of radiation treatment showed that the fractionated radiotherapy significantly increased the abundance of CD133+ tumor cells, and drove quiescent G0 phase cells (both CD133+ and CD133-) into G1 phase in both models. Immunohistochemical examination of key regulators of stem cell self-renewal revealed elevation of BMI-1 and SOX2 gene expression in vivo in the xenograft tumors. Additionally, we found that radiotherapy promoted mesenchymal transition, as the intensity and distribution of fibronectin, a mesenchymal marker, was remarkably enhanced. Further analysis of the recurrent xenograft tumors ∼ 5 weeks post-fractionated radiation showed that the increased CD133+ fraction, the elevated expressions of BMI-1 and SOX2 as well as fibronection were maintained. In conclusion, our data demonstrated, for the first time, that failure of radiotherapy is mediated by activated pathways related to self-renewal of cancer stem cells and mesenchymal transition. Since this study was conducted in vivo in clinically relevant animal models in a setting that is the closest to human brain tumors, our findings provided strong preclinical evidence to suggest that new stratigies are needed to inhibit these radiation triggered-pathways to improved therapeutic efficacy in pediatric GBM patient. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 570. doi:10.1158/1538-7445.AM2011-570

Bmi-1 induces radioresistance by suppressing senescence in human U87 glioma cells.

Bmi-1 Confers Adaptive Radioresistance to Kyse-150r Esophageal Carcinoma Cells

Bmi-1 Induces Radioresistance in MCF-7 Mammary Carcinoma Cells.

Downregulation of BMI1 Induces Glioma Stem Cells Sensitive to Radiation

B-Myb participated in ionizing radiation-induced apoptosis and cell cycle arrest in human glioma cells

Irradiation induces glioblastoma cell senescence and senescence-associated secretory phenotype

ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways

Oncoprotein Bmi-1 Renders Apoptotic Resistance to Glioma Cells Through Activation of the IKK-nuclear Factor-Kappab Pathway.

Inhibition of Mitochondria NADH-Ubiquinone Oxidoreductase (complex I) Sensitizes the Radioresistant Glioma U87MG Cells to Radiation.

Effect of Radiation on the Radiosensitivity of a Human Malignant Glioma Cell Line

PD-L1 Inhibitor Regulates the miR-33a-5p/PTEN Signaling Pathway and Can Be Targeted to Sensitize Glioblastomas to Radiation

Alteration of Dna Damage Signaling Pathway Profile in Radiation-Treated Glioblastoma Stem-Like Cells

Preliminary Study on Radioresistance and Relevant Mechanisms of Human Cerebral Glioma Stem/pro-Genitor Cell Line SU-2

CBIO-11. NOVEL THERAPY TO TARGET PR-RECURRENT GLIOMA

Bmi-1 Promotes Glioma Angiogenesis by Activating NF-κB Signaling.

Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells

Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence

Bip inhibition in glioma stem cells promotes radiation-induced immunogenic cell death

Abstract 570: Radiation Resistance of Orthotopic Glioblastoma Xenografts is Mediated by Increasing CD133+ Cell Fraction, Mobilizing G0 Cells into G1 Phase, and Activating Self-Renewal and Mesenchymal Genes

YM155 Decreases Radiation-Induced Invasion and Reverses Epithelial–mesenchymal Transition by Targeting STAT3 in Glioblastoma

Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/ Progenitor Cells.